-
Product Insights
NewC-C Motif Chemokine 2 – Drugs In Development, 2024
The C-C Motif Chemokine 2 pipeline drugs market research report outlays comprehensive information on the C-C Motif Chemokine 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Ophthalmology, and Gastrointestinal which include indications of Oncology, Ovarian Cancer, Dry (Atrophic) Macular Degeneration, Diabetic Retinopathy, Metabolic Dysfunction-Associated Steatohepatitis (MASH), and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). It also...
-
Product Insights
NewC-C Chemokine Receptor Type 8 – Drugs In Development, 2024
The C-C Chemokine Receptor Type 8 pipeline drugs market research report outlays comprehensive information on the C-C Chemokine Receptor Type 8 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Toxicology, and Central Nervous System which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Opioid Induced Side Effects, Alzheimer's Disease, and Neuropathic Pain (Neuralgia). It also...
-
Product Insights
NewC-C Chemokine Receptor Type 2 – Drugs In Development, 2024
The C-C Chemokine Receptor Type 2 pipeline drugs market research report outlays comprehensive information on the C-C Chemokine Receptor Type 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Genito Urinary System, Central Nervous System, and Gastrointestinal which include indications of Colorectal Cancer, Hepatocellular Carcinoma, Focal Segmental Glomerulosclerosis (FSGS), Diabetic Nephropathy, Alzheimer's Disease, Neuropathic Pain (Neuralgia),...
-
Product Insights
NewC-C Chemokine Receptor Type 4 – Drugs In Development, 2024
The C-C Chemokine Receptor Type 4 pipeline drugs market research report outlays comprehensive information on the C-C Chemokine Receptor Type 4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Respiratory, Dermatology, and Undisclosed which include indications of Non-Hodgkin Lymphoma, Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma), Asthma, Allergic Asthma, Atopic Dermatitis (Atopic Eczema), Chronic Urticaria Or Hives, and...
-
Product Insights
NewC-C Chemokine Receptor Type 5 – Drugs In Development, 2024
The C-C Chemokine Receptor Type 5 pipeline drugs market research report outlays comprehensive information on the C-C Chemokine Receptor Type 5 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease, Oncology, Central Nervous System, and Gastrointestinal which include indications of Human Immunodeficiency Virus (HIV) Infections (AIDS), Coronavirus Disease 2019 (COVID-19), Metastatic Colorectal Cancer, Gastric Cancer, Multiple...
-
Product Insights
NewC-X-C Chemokine Receptor Type 2 – Drugs In Development, 2024
The C-X-C Chemokine Receptor Type 2 pipeline drugs market research report outlays comprehensive information on the C-X-C Chemokine Receptor Type 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Respiratory, and Metabolic Disorders which include indications of Solid Tumor, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Inflammation, Autoimmune Disorders, Acute Respiratory Distress Syndrome, Chronic Obstructive Pulmonary Disease...
-
Product Insights
NewC-X-C Chemokine Receptor Type 3 – Drugs In Development, 2024
The C-X-C Chemokine Receptor Type 3 pipeline drugs market research report outlays comprehensive information on the C-X-C Chemokine Receptor Type 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Metabolic Disorders, and Ophthalmology which include indications of Unspecified Cancer, Solid Tumor, Autoimmune Disorders, Unspecified Immunological Disorders, Type 1 Diabetes (Juvenile Diabetes), and Wet (Neovascular /...
-
Product Insights
NewC-X-C Chemokine Receptor Type 1 – Drugs In Development, 2024
The C-X-C Chemokine Receptor Type 1 pipeline drugs market research report outlays comprehensive information on the C-X-C Chemokine Receptor Type 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Metabolic Disorders, and Dermatology which include indications of Metastatic Colorectal Cancer, Solid Tumor, Psoriasis, Inflammation, Obesity, Type 1 Diabetes (Juvenile Diabetes), and Hidradenitis Suppurativa. It also...
-
Product Insights
NewC-X-C Chemokine Receptor Type 4 – Drugs In Development, 2024
The C-X-C Chemokine Receptor Type 4 pipeline drugs market research report outlays comprehensive information on the C-X-C Chemokine Receptor Type 4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Infectious Disease, and Dermatology which include indications of Solid Tumor, Oncology, Transplant Rejection, Autoimmune Disorders, Coronavirus Disease 2019 (COVID-19), Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress...
-
Product Insights
NewC-X-3-C Motif Chemokine Receptor – Drugs In Development, 2024
The C-X-3-C Motif Chemokine Receptor pipeline drugs market research report outlays comprehensive information on the C-X-3-C Motif Chemokine Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, Central Nervous System, Oncology, and Immunology which include indications of Myocardial Infarction, Atherosclerosis, Alzheimer's Disease, Secondary Progressive Multiple Sclerosis (SPMS), Ovarian Cancer, Chronic Lymphocytic Leukemia (CLL), and Inflammation. It...